Cannabis Addiction: What It Is, How to Recognise It, and How It's Treated

About 2.8% of people in India currently use cannabis. That works out to roughly 3.1 crore people (AIIMS-NIMHANS National Survey on Extent and Pattern of Substance Use in India, 2019). Most of them will never develop a problem with it. A meaningful number will.
Picture of Medically Reviewed By Dr. Naveen Kumar V
Medically Reviewed By Dr. Naveen Kumar V

MBBS, DPM (Psychiatry),Abhasa Rehab and Wellness
Clinical Lead with 20 years of experience in addiction psychiatry

Picture of Medically Reviewed By <br>Dr. Naveen Kumar V
Medically Reviewed By
Dr. Naveen Kumar V

MBBS, DPM (Psychiatry),Abhasa Rehab and Wellness
Clinical Lead with 20 years of experience in addiction psychiatry

cannabis-addiction-treatment
2.8%[1]

of people in India currently use cannabis

22%[4]

Of people who use cannabis develop cannabis use disorder

33%[4]

Among young people using weekly or more

20+ years

Dr. Naveen Kumar clinical experience in addiction psychiatry

Table of Contents

Key Takeaways

QUICK ANSWER

What is cannabis addiction? Cannabis addiction is a treatable brain condition in which a person keeps using cannabis despite the harm it causes and struggles to cut down when they try. Doctors call it cannabis use disorder. Around 22% of people who use cannabis go on to develop it[4]

Here’s the difficulty. Cannabis carries a reputation for being harmless, and that reputation is why families wait. They wait for something dramatic. Often nothing dramatic happens. What happens instead is slow, and by the time it’s obvious, several years have usually passed.

 

This page walks through what cannabis addiction is in clinical terms, how doctors recognise it, why it develops, what cannabis does to the body and mind, and which treatments actually have evidence behind them.

What Is Cannabis Addiction?

Cannabis addiction is a medical diagnosis given when repeated cannabis use starts to impair a person’s health, relationships or daily functioning, and they cannot stop despite wanting to. The Diagnostic and Statistical Manual of Mental Disorders, fifth edition, calls this cannabis use disorder and lists eleven criteria for it.[3]

 

Those eleven criteria fall into four groups. It helps to see them that way rather than as a list.

A person needs at least two of these within a twelve-month period for the diagnosis. The World Health Organization’s ICD-11 describes the same condition slightly differently, focusing on impaired control, cannabis taking priority over other things, and continued use despite harm.

 

Two things are worth saying plainly. First, this is a health condition with diagnostic criteria, not a judgement about character. Second, most people who use cannabis do not meet these criteria and never will. Both things are true at once.

 

You can read more about the substances we work with on our cannabis page and our wider what we treat overview.

How Common Is Cannabis Addiction?

QUICK ANSWER

About 2.8% of people in India aged 10 to 75 used a cannabis product in the past year, roughly 3.1 crore people[1]. Of people who use cannabis anywhere in the world, around 22% develop cannabis use disorder, rising to about 33% among young people using weekly or more[4].

In India, the AIIMS-NIMHANS national survey found that about 2.8% of people aged 10 to 75 had used cannabis products in the previous year, which is roughly 3.1 crore people. Bhang accounted for a large share of that use, with ganja and charas making up the rest.

 

Globally, the picture on risk is clearer than the picture on numbers. A systematic review and meta-analysis found that around 22% of people who use cannabis develop cannabis use disorder at some point[4]. Among young people using weekly or more often, that figure rose to roughly 33%.

 

Age at first use matters, and it matters a great deal. Starting in adolescence is associated with higher rates of later problems than starting as an adult, and the evidence on adolescent exposure has been consistent on this point for years [6].

 

There’s an Indian dimension to this that’s easy to miss. Bhang has a long cultural and religious history here, and it’s often not thought of as a drug at all. That familiarity is genuinely protective in some ways, because use is frequently occasional and social rather than solitary and daily.

 

But it also means a person can drift from festival use to daily use without anyone naming what’s happening, including themselves.

 

The same national survey also found a substantial gap between the number of people who need help for substance use in India and the number who receive it. Stigma is part of that. So is the belief that cannabis is not serious enough to warrant treatment, which delays help until problems have compounded.

 

So the honest summary is this. Most people who use cannabis will be fine. About one in five will not. And the younger someone starts, the worse those odds get.

How Do You Recognise Cannabis Addiction?

Cannabis addiction is recognised by counting how many of the eleven diagnostic criteria a person meets over twelve months, then grading severity from that count.

 

Two or three criteria indicate a mild disorder. Four or five indicate moderate. Six or more indicate severe. The count matters more than any single symptom[3].

 

That grading is genuinely useful, because it maps onto what kind of help someone is likely to need.

Severity Criteria met What it often looks like Level of care usually considered
Severity Mild
Criteria met 2 to 3
What it often looks like Using more than planned, some failed attempts to cut back, use continuing despite minor friction at home or work
Level of care usually considered Outpatient counselling, brief structured therapy
Severity Moderate
Criteria met 4 to 5
What it often looks like Daily or near-daily use, tolerance, responsibilities slipping, activities dropped, withdrawal on stopping
Level of care usually considered Structured outpatient programme or day programme
Severity Severe
Criteria met 6 or more
What it often looks like Use organises the day, marked withdrawal, significant impact on work or study, often alongside another mental health condition
Level of care usually considered Residential treatment with medical and psychiatric support

There’s a question underneath all of this that families ask constantly. Where is the line between heavy use and dependence?

 

Three signals separate them more reliably than volume does. Tolerance, where the same amount stops working. Failed attempts to cut down, particularly repeated ones. And withdrawal, where stopping produces real physical and emotional symptoms. Someone can use a lot without any of these. Someone else can use less and have all three.

 

An important limit here. This page describes how clinicians think; it is not a diagnostic tool, and reading a list of criteria is not the same as being assessed. Only a qualified clinician can diagnose cannabis use disorder, and doing so involves history, context and ruling out other explanations.

 

If you’re weighing this up for yourself or someone close to you, our do I need rehab page is a gentler place to start, and our cannabis addiction treatment page explains what assessment involves.

Why Does Cannabis Addiction Happen?

Nobody enjoys giving that answer to a family who came in hopeful. But a softer answer would be a worse one.

Cannabis addiction develops through a mix of biology, timing and circumstance. Regular use affects the brain systems that manage reward, motivation and stress, and repeated exposure changes how those systems respond[2].

 

Age at first use, genetic vulnerability and untreated mental health problems all raise the risk further.

 

Four factors do most of the work.

That last factor is why assessment matters so much. If cannabis is managing an untreated anxiety disorder, removing the cannabis without treating the anxiety tends not to hold. Our dual diagnosis page explains how we treat co-occurring conditions together.

What Does Cannabis Do to the Body and Mind?

QUICK ANSWER

Cannabis acutely impairs coordination, memory, attention and judgement. Chronic heavy use is associated with decline in attention and working memory[23], with increased risk of psychotic illness at high potency and daily use [9], and with respiratory symptoms when smoked.

The effects fall into short-term and long-term, and the strength of evidence varies a lot between them. Where the evidence is uncertain, this section says so.

What Happens During Cannabis Withdrawal?

Cannabis withdrawal typically begins within one to two days of stopping, peaks over the first week, and settles across two to four weeks.

 

Common symptoms include irritability, difficulty sleeping, vivid dreams, reduced appetite, restlessness and low mood[14]. It is rarely medically dangerous, but it is a frequent reason people return to use.

Stage Timing What usually happens
Stage Onset
Timing 24 to 48 hours after stopping
What usually happens Irritability, restlessness, trouble falling asleep
Stage Peak
Timing Days 2 to 6
What usually happens Sleep disruption and vivid dreams, low appetite, low mood, strong craving
Stage Settling
Timing Weeks 2 to 4
What usually happens Symptoms ease steadily; sleep is often the last thing to normalise
Stage Lingering
Timing Beyond 4 weeks
What usually happens Occasional sleep difficulty and craving in some people

Trajectories vary between individuals, and research using modelling of withdrawal patterns has found meaningfully different courses across people going through detoxification[15].

 

Here’s why this matters practically. Someone who says “I tried to stop and felt awful, so I clearly need it” is not making an excuse. They’re describing withdrawal. And withdrawal is a reason to get support, not a reason to continue.

 

Medical supervision is not always necessary for cannabis alone, but it becomes important when other substances are involved, when there’s a significant mental health condition, or when previous attempts have failed. Our detoxification and detox programme pages explain how our clinical team manages this.

How Is Cannabis Addiction Treated?

Treatment for cannabis addiction is primarily psychological. There is currently no medication approved specifically for cannabis use disorder, and a Cochrane review of pharmacotherapies for cannabis dependence found none established for this purpose[16].

 

Recent consensus guidance on pharmacological management of substance dependence reaches similar conclusions for cannabis[17].

 

That sounds discouraging. It isn’t, because the psychological treatments have reasonable evidence behind them.

The evidence, strongest first

Cognitive behavioural therapy and motivational approaches: These are the backbone. A systematic review and meta-analysis of motivational interviewing for cannabis use disorders found it produced measurable reductions in use [18]. Reviews of interventions for cannabis use disorder consistently place combined cognitive behavioural and motivational approaches at the front [19].

Contingency management: This adds structured reinforcement for verified abstinence, and it has been studied specifically in cannabis use disorder[20]. The evidence here needs stating honestly rather than optimistically. It can increase abstinence while the programme is running, but a randomised trial found that adding contingency management to cognitive behavioural therapy did not improve success rates for all groups of people with cannabis dependence[22], and gains may fade once the reinforcement stops. It is a useful component for some people, not a guaranteed upgrade.

Family-based approaches for adolescents: For young people, treatments involving the family have the strongest evidence base[21]. This is one area where the age of the person genuinely changes the recommended approach.

Medication for what sits underneath: No medicine treats cannabis use disorder directly. But if someone has an anxiety disorder, depression or a psychotic illness alongside it, those are treatable, and treating them properly changes the odds.

What treatment actually looks like, step by step

What recovery realistically looks like

It’s worth being straight about this, because unrealistic expectations cause a lot of avoidable discouragement.

Return to use is common during recovery from any substance use disorder, and it does not mean treatment has failed. It usually means a trigger was met without a plan for it. Most structured programmes treat a lapse as information about what needs strengthening rather than as a verdict on the person.

Sleep tends to be the slowest thing to settle. Many people find it takes several weeks before sleep feels normal again, and knowing that in advance stops it from being read as a sign that something is wrong. Mood and appetite generally recover sooner.

What tends to predict a better outcome is fairly consistent: treating co-occurring conditions properly rather than later, having structure in the months after treatment rather than only during it, and having at least some people around who know what’s going on.

You can read about the therapies we use on our schools of therapy page, our how we treat overview, and the guide to treatment approaches.

How Abhasa Rehab and Wellness Treats Cannabis Addiction

Care at Abhasa Rehab and Wellness begins with a clinical assessment, moves into structured psychological treatment, and continues through a planned period of aftercare. Cannabis use disorder is treated alongside any anxiety, low mood or trauma found during assessment rather than after it.

 

Care at Abhasa Rehab and Wellness is clinically led. Assessment and treatment are overseen by qualified psychiatrists, including Dr. Naveen Kumar, MBBS, DPM (Psychiatry), a consulting psychiatrist with over 20 years of experience in addiction psychiatry and dual diagnosis, and Dr. Shree Aarthi, MBBS, MD, DNB, whose work focuses on mental health and substance use disorders.

 

Medical cover is continuous. Dr. Malarvilzhi G, MBBS, MD provides residential medical supervision, which matters when withdrawal is complicated by other substances or by a physical health problem.

 

Clinical psychologists trained in the approaches the evidence supports deliver the psychological treatment. Ms. Meera K, M.Phil Clinical Psychology, works in trauma and behavioural health, including cognitive behavioural and trauma-focused therapy.

 

That combination matters here specifically, because cannabis so often arrives alongside anxiety, low mood or unresolved trauma that needs treating at the same time.

Families are part of the work rather than an afterthought, which our family support page describes. If you want to understand what admission involves before deciding anything, our admission guide sets out the process step by step, and our cannabis addiction treatment page covers the programme itself.

Frequently Asked Questions

Taking the Next Step

If you’ve read this far, you’re probably not asking out of curiosity. Something has been sitting with you for a while.

Here’s what the evidence supports. Cannabis use disorder is a recognised condition with graded severity, understood risk factors and treatments that have been tested. It responds to structured psychological treatment.

Outcomes tend to be better when co-occurring anxiety, depression or trauma are treated at the same time rather than left for later. Earlier intervention is generally associated with better results than waiting.

None of that requires a crisis first. Assessment is just a conversation with a clinician about what’s actually happening, and it commits you to nothing.

Recovery from cannabis addiction is realistic. Our page on life after rehab describes what the months afterwards involve, and you can reach us through our contact page whenever you’re ready to ask a question.

Talk to Abhasa’s clinical team confidentially.

Call+91-73736-44444 or Email info@abhasa.in. Our compassionate team understands what you’re going through.

Continue Learning

About the Author

Written by: Abhasa Rehab and Wellness Clinical Content Team.

Medically reviewed by Dr. Naveen Kumar, MBBS, DPM (Psychiatry), Medical Director at Abhasa Rehab and Wellness, a consulting psychiatrist with over 20 years of experience in addiction psychiatry and dual diagnosis.

This page is based on peer-reviewed evidence from the sources listed below. Every clinical claim was verified against PubMed-indexed literature or Tier 1 public health sources before publication.

[1] Ambekar A, et al. Magnitude of Substance Use in India: National Survey. Ministry of Social Justice and Empowerment / AIIMS-NIMHANS, 2019. https://socialjustice.gov.in/writereaddata/UploadFile/Survey%20Report.pdf

[2] Connor JP, Stjepanović D, Le Foll B, Hoch E, Budney AJ, Hall WD. Cannabis use and cannabis use disorder. Nature Reviews Disease Primers, 2021. https://pubmed.ncbi.nlm.nih.gov/33627670/

[3] Hasin DS, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. American Journal of Psychiatry, 2013. https://pubmed.ncbi.nlm.nih.gov/23903334/

[4] Leung J, et al. What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis, 2020. https://pubmed.ncbi.nlm.nih.gov/32485547/

[5] Chandra S, et al. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time. Addiction, 2021. https://pubmed.ncbi.nlm.nih.gov/33160291/

[6] Evidence for the Risks and Consequences of Adolescent Cannabis Exposure. Journal of the American Academy of Child and Adolescent Psychiatry, 2017. https://pubmed.ncbi.nlm.nih.gov/28219487/

[7] Acute and Chronic Effects of Cannabinoids on Human Cognition: A Systematic Review. Biological Psychiatry, 2016. https://pubmed.ncbi.nlm.nih.gov/26858214/

[8] Cannabis Use Characteristics Associated with Self-Reported Cognitive Function. Substance Use & Misuse, 2024. https://pubmed.ncbi.nlm.nih.gov/38664196/

[9] Di Forti M, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe. The Lancet Psychiatry, 2019. https://pubmed.ncbi.nlm.nih.gov/30902669/

[10] Cannabis and Mental Health: A Review. JAMA Internal Medicine, 2026. https://pubmed.ncbi.nlm.nih.gov/41801216/

[11] Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. European Archives of Psychiatry and Clinical Neuroscience, 2025. https://pubmed.ncbi.nlm.nih.gov/39299947/

[12] Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment: a Systematic Review. Journal of Medical Toxicology, 2017. https://pubmed.ncbi.nlm.nih.gov/28000146/

[13] A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options. Medical Principles and Practice, 2022. https://pubmed.ncbi.nlm.nih.gov/34724666/

[14] Connor JP, et al. Clinical management of cannabis withdrawal. Addiction, 2022. https://pubmed.ncbi.nlm.nih.gov/34791767/

[15] Fischer B, et al. Exploratory growth mixture modeling of cannabis-withdrawal syndrome trajectories during detoxification, 2023. https://pubmed.ncbi.nlm.nih.gov/37462539/

[16] Nielsen S, et al. Pharmacotherapies for cannabis dependence. Cochrane Database of Systematic Reviews, 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360924/

[17] Evidence-based consensus guidelines for the pharmacological management of substance dependence. Journal of Psychopharmacology, 2026. https://pubmed.ncbi.nlm.nih.gov/41731947/

[18] Motivational Interviewing for Cannabis Use Disorders: A Systematic Review and Meta-Analysis. European Addiction Research, 2021. https://pubmed.ncbi.nlm.nih.gov/33965941/

[19] Brezing CA, Levin FR. Interventions for cannabis use disorder, 2021. https://pubmed.ncbi.nlm.nih.gov/33338844/

[20] Sherman BJ, et al. Contingency management for cannabis use disorder treatment, 2024. https://pubmed.ncbi.nlm.nih.gov/39374591/

[21] Gray KM, Squeglia LM. Treatment of adolescent cannabis use disorders, 2023. https://pubmed.ncbi.nlm.nih.gov/37879838/

[22] Carroll KM, et al. Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence, 2012. https://pubmed.ncbi.nlm.nih.gov/22404223/

[23] de Souza Queiroz AP, et al. Cognitive Effects of Cannabis Use: A Comprehensive Review, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12300094/

[24] Cannabinoid Hyperemesis Syndrome. StatPearls, National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK549915/

[25] DSM-5-TR Criteria for Diagnosing and Classifying Substance Use Disorders. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK565474/table/table-3/

[26] NDDTC, AIIMS. Magnitude of Substance Use in India report summary. Press Information Bureau, Government of India, 2019. https://www.pib.gov.in/Pressreleaseshare.aspx?PRID=1565001

Dr. Naveen Kumar V is a senior consultant psychiatrist with over 20 years of clinical experience specializing in addiction psychiatry, dual diagnosis treatment, and comprehensive mental health care. As the longest-tenured medical professional at Abhasa Rehabilitation Centre, he serves as the primary medical authority for psychiatric treatment protocols.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult qualified healthcare professionals for medical concerns. Individual outcomes vary based on multiple factors, including treatment adherence and co-occurring conditions.

Rehab & Online Therapy

Take the First Step Toward Healing

Confidential support from Abhasa’s licensed team — online from home, or in-person at our centres. No pressure, no judgement.

Online Therapy

Secure video or phone consultation from home.

In-Person Rehab

Residential care at our centres in Coimbatore, near Mumbai and in Telangana.

or talk to us now